Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 12/20 | 0.67 |
| ▸ | MEN1 | O00255 | 11/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.67 |
| ▸ | POLB | P06746 | 10/20 | 0.67 |
| ▸ | RECQL | P46063 | 9/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 8/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.67 |
| ▸ | THRB | P10828 | 6/20 | 0.67 |
| ▸ | USP2 | O75604 | 5/20 | 0.67 |
| ▸ | BLM | P54132 | 4/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.67 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.67 |
| ▸ | MMP2 | P08253 | 1/20 | 0.67 |
| ▸ | NSD2 | O96028 | 4/20 | 0.52 |
| ▸ | ALPL | P05186 | 3/20 | 0.52 |
| ▸ | APAF1 | O14727 | 1/20 | 0.52 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.52 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.52 |
| ▸ | APEX1 | P27695 | 5/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15502362 | 0.89 | MAPT (0.56) | MAPTMEN1KMT2APOLBRECQL | |
| SCHEMBL26458902 | 0.80 | MAPT (1.00) | MAPTMEN1KMT2APOLBRECQL | |
| SCHEMBL14680220 | 0.80 | MAPT (1.00) | MAPTMEN1KMT2APOLBRECQL | |
| SCHEMBL15502311 | 0.74 | ALDH1A1 (0.47) | MAPTMEN1KMT2APOLBRECQL | |
| SCHEMBL18598496 | 0.72 | MAPT (0.83) | MAPTMEN1KMT2APOLBRECQL | |
| SCHEMBL14680251 | 0.71 | MAPT (0.78) | MAPTMEN1KMT2APOLBRECQL | |
| SCHEMBL15502320 | 0.71 | KMT2A (0.46) | MAPTMEN1KMT2APOLBL3MBTL1 | |
| SCHEMBL15502366 | 0.71 | AADAT (0.53) | MAPTMEN1KMT2APOLBRECQL | |
| SCHEMBL13587027 | 0.71 | BCL2 (0.49) | MAPTMEN1KMT2APOLBL3MBTL1 | |
| SCHEMBL15617083 | 0.71 | MAPT (0.46) | MAPTMEN1KMT2APOLBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10195213-B2 | Chemical entities that kill senescent cells for use in treating age-related disease | UNITY BIOTECHNOLOGY, INC. (US) | 2019-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10195213-B2 | Chemical entities that kill senescent cells for use in treating age-related disease | TP53, CDKN1A, GLA | MAPT 1460/4885MEN1 2434/4885KMT2A 2501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.